Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies.

Oken BS.

Neurology. 2009 Jun 9;72(23):2053; author reply 2053-4. doi: 10.1212/01.wnl.0000349697.25117.41. No abstract available.

PMID:
19506232
3.

Can CER be an effective tool for change in the development and assessment of new drugs and technologies?

Brixner DI, Watkins JB.

J Manag Care Pharm. 2012 Jun;18(5 Supp A):S06-11.

PMID:
22663293
4.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2011 Apr;72(4):464-72. doi: 10.4088/JCP.10m06191. Erratum in: J Clin Psychiatry. 2011 Jun;72(6):874.

PMID:
21527123
5.

Tablet splitting.

[No authors listed]

Med Lett Drugs Ther. 2012 Aug 6;54(1396):63. Review. No abstract available.

PMID:
22869291
6.

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.

Crofford LJ, Mease PJ, Simpson SL, Young JP Jr, Martin SA, Haig GM, Sharma U.

Pain. 2008 Jun;136(3):419-31. doi: 10.1016/j.pain.2008.02.027. Epub 2008 Apr 8.

PMID:
18400400
7.

Best outcomes may be salvation for shriveling managed care cost savings.

Egger E.

Health Care Strateg Manage. 1999 Mar;17(3):12-3.

PMID:
10351641
8.

The placebo effect: advances from different methodological approaches.

Meissner K, Bingel U, Colloca L, Wager TD, Watson A, Flaten MA.

J Neurosci. 2011 Nov 9;31(45):16117-24. doi: 10.1523/JNEUROSCI.4099-11.2011. Review.

9.

Pharmacological fMRI--challenges in analysing drug-induced single-event BOLD responses.

Pohlmann A, Barjat H, Tilling LC, James MF.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3411-6.

PMID:
18002730
10.

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2012 Jun;73(6):856-64. doi: 10.4088/JCP.11r07539. Epub 2012 May 15. Review.

PMID:
22687813
11.

The placebo response: neurobiological and clinical issues of neurological relevance.

Pollo A, Benedetti F.

Prog Brain Res. 2009;175:283-94. doi: 10.1016/S0079-6123(09)17520-9. Review.

PMID:
19660663
12.

Measuring costs: administrative claims data, clinical trials, and beyond.

Etzioni R, Riley GF, Ramsey SD, Brown M.

Med Care. 2002 Jun;40(6 Suppl):III63-72. Review.

PMID:
12064760
13.

Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy.

Grossi F, Genova C, Gaitan ND, Dal Bello MG, Rijavec E, Barletta G, Sini C, Donato C, Beltramini S, Pronzato P, Porcile G, Boccardo F, Walzer S.

Lung Cancer. 2013 Aug;81(2):236-40. doi: 10.1016/j.lungcan.2013.03.021. Epub 2013 May 4.

PMID:
23648072
14.

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.

Willke RJ, Burke LB, Erickson P.

Control Clin Trials. 2004 Dec;25(6):535-52. Review.

PMID:
15588741
15.

What do you expect from this treatment? Changing our mind about clinical trials.

Benedetti F.

Pain. 2007 Apr;128(3):193-4. Epub 2007 Feb 9. No abstract available.

PMID:
17292547
16.

Assessing dose-region profile of drug efficacy: a multiregional trial strategy.

Chen YH, Wang M.

J Biopharm Stat. 2012 Sep;22(5):894-902. doi: 10.1080/10543406.2012.701577. Review.

PMID:
22946938
17.

Tablet splitting.

[No authors listed]

Med Lett Drugs Ther. 2009 Aug 10;51(1318):62-3.

PMID:
19661854
18.

Pharmaceutical step-therapy interventions: a critical review of the literature.

Motheral BR.

J Manag Care Pharm. 2011 Mar;17(2):143-55. Review.

19.

Economic advantage of pharmacogenomics - clinical trials with genetic information.

Ohashi W, Mizushima H, Tanaka H.

Stud Health Technol Inform. 2008;136:585-90.

PMID:
18487794
20.

Bone graft substitutes for the treatment of traumatic fractures of the extremities.

Hagen A, Gorenoi V, Schönermark MP.

GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.

Supplemental Content

Support Center